одобрен

Приложение 4 на ПЛС от 02.10.2020 г.

Уникален идентификатор:  9c8162ef-5c30-4c3c-ae8b-09bec0f8f412

Описание:

Приложение 4 на ПЛС от 02.10.2020 г.

РМС 214/2016

Текуща версия: 2

Показвана версия: 1

Формат: CSV

  • Създаден на: 2020-10-05 14:44:21
  • Създаден от: georgi_sivchev
  • Последна промяна: 2020-10-15 10:22:27
  • Последно променил: georgi_sivchev
записа на страница

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Palonosetron EU/1/04/306/001 ALOXI, Solution for injection, 250 mcg/5 ml, -, Pack: 1 Helsinn Birex Pharmaceuticals Ltd., Ирландия Helsinn Birex Pharmaceuticals Ltd, Ireland 55.47 11.09 66.56 4% 2.22 57.69 11.54 69.23 16% 8.88 66.57 13.31 79.88 Прот. № 220/20.04.2017 г. НСР-5458/16.01.2015; НСР-9209/ 05.05.2016; НСР-13552/18.08.2017; НСР-17088/26.10.2018 10.11.2018 02.12.2018 Активен 3521
Palonosetron EU/1/04/306/001 ALOXI, Solution for injection, 250 mcg/5 ml, -, Pack: 1 Helsinn Birex Pharmaceuticals Ltd., Ирландия Helsinn Birex Pharmaceuticals Ltd, Ireland 68.53 13.71 82.24 4% 2.74 71.27 14.25 85.52 16% 10.96 82.23 16.45 98.68 Прот. № 220/20.04.2017 г. НСР-5458/16.01.2015; НСР-9209/ 05.05.2016; НСР-13552/18.08.2017 02.09.2017 02.10.2017 Неактивен 3521
Palonosetron EU/1/04/306/001 ALOXI, Solution for injection, 250 mcg/5 ml, -, Pack: 1 Helsinn Birex Pharmaceuticals Ltd., Ирландия Helsinn Birex Pharmaceuticals Ltd, Ireland 107.75 21.55 129.3 4% 4.31 112.06 22.41 134.47 16% 17.24 129.3 25.86 155.16 Прот. № 220/20.04.2017 г. НСР-5458/16.01.2015; НСР-9209/ 05.05.2016 02.06.2016 02.05.2017 Неактивен 3521
Palonosetron EU/1/04/306/001 ALOXI, Solution for injection, 0,05 mg/ml - 5 ml, mg, Pack: 1 Helsinn Birex Pharmaceuticals Ltd., Ирландия Helsinn Birex Pharmaceuticals Ltd, Ireland 107.75 21.55 129.3 4% 4.31 112.06 22.41 134.47 16% 17.24 129.3 25.86 155.16 НСР-5458/16.01.2015; НСР-9209/ 05.05.2016 02.06.2016 02.06.2016 Неактивен 3521
Palonosetron EU/1/04/306/001 ALOXI, Solution for injection, 0,05 mg/ml - 5 ml, mg, Pack: 1 Helsinn Birex Pharmaceuticals Ltd., Ирландия Helsinn Birex Pharmaceuticals Ltd, Ireland 108.65 21.73 130.38 4% 4.35 113 22.6 135.6 16% 17.38 130.38 26.08 156.46 НСР-5458/16.01.2015 02.02.2015 02.02.2015 Неактивен 3521
Palonosetron EU/1/04/306/001 ALOXI, Solution for injection, 0,05 mg/ml - 5 ml, mg, Pack: 1 Helsinn Birex Pharmaceuticals Ltd., Ирландия Helsinn Birex Pharmaceuticals Ltd, Ireland 116.92 23.38 140.3 4% 4.68 121.6 24.32 145.92 16% 18.71 140.31 28.06 168.37 НСР-3177/07.04.2014 12.05.2014 12.05.2014 Неактивен 3521
Palonosetron EU/1/04/306/001 ALOXI, Solution for injection, 0,05 mg/ml - 5 ml, mg, Pack: 1 Helsinn Birex Pharmaceuticals Ltd., Ирландия Helsinn Birex Pharmaceuticals Ltd, Ireland 124.47 24.89 149.36 4% 4.98 129.45 25.89 155.34 16% 19.92 149.37 29.87 179.24 върната жалба от Комисия по прозрачност с писмо № КЦР-589/10.04.2013 КЦРР-389/29.03.2012 02.07.2013 02.07.2013 Неактивен 3521
Palonosetron EU/1/04/306/001 ALOXI, Solution for injection, 0,05 mg/ml - 5 ml, mg, Pack: 1 Helsinn Birex Pharmaceuticals Ltd., Ирландия Helsinn Birex Pharmaceuticals Ltd, Ireland 131.04 26.21 157.25 4% 5.24 136.28 27.26 163.54 16% 20.97 157.25 31.45 188.7 КЦ-421/10.01.2009 06.02.2009 06.02.2009 Неактивен 3521
Cefepime 20140246 Alphacef, Powder for solution for injection, 1, g, Pack: 10 Medochemie Ltd., Кипър Medochemie Ltd., (Factory C), Mich. Erakleous, Agios Athanasios Industrial Area, Limassol, Кипър 94.16 18.83 112.99 4% 3.77 97.93 19.59 117.52 16% 15.07 113 22.6 135.6 НСР-6706/16.07.2015.; НСР-16967/12.10.2018 27.10.2018 02.11.2018 Активен 4041
Cefepime 20140246 Alphacef, Powder for solution for injection, 1, g, Pack: 10 Medochemie Ltd., Кипър Medochemie Ltd., (Factory C), Mich. Erakleous, Agios Athanasios Industrial Area, Limassol, Кипър 175.44 35.09 210.53 4% 7.02 182.46 36.49 218.95 16% 25 207.46 41.49 248.95 НСР-6706/16.07.2015. 01.08.2015 01.08.2015 Неактивен 4041
Alfacalcidol II - 15922/29.12.2006 Alpha D3, Capsule, soft, 0.5, mcg, Pack: 30 Тева Фармасютикълс България ЕООД, България Teva Pharmaceutical Industries Limited, Israel Teva Pharma BV, The Netherlands Pharmachemie B.V., The Netherlands 8.02 1.6 9.62 7% 0.56 8.58 1.72 10.3 20% 1.6 10.18 2.04 12.22 Цената се заличава с решение НСР-295307.03.2014; Отхвърлена жалба от Комисия по прозрачност с решение КП-45/05.03.2015 и НСР-2005/11.12.2013 НСР-1807/25.11.2013 11.12.2013 11.12.2013 Заличен 2306
Alfacalcidol II - 15921/29.12.2006 Alpha D3, Capsule, soft, 0.25, mcg, Pack: 30 Тева Фармасютикълс България ЕООД, България Teva Pharmaceutical Industries Limited, Israel Teva Pharma BV, The Netherlands Pharmachemie B.V., The Netherlands 4.01 0.8 4.81 7% 0.28 4.29 0.86 5.15 20% 0.8 5.09 1.02 6.11 Цената се заличава с решение НСР-2715/06.02.2014 НСР-1807/25.11.2013 11.12.2013 11.12.2013 Заличен 2305
Alfacalcidol II - 15923/29.12.2006 Alpha D3, Capsule, soft, 1, mcg, Pack: 30 Тева Фармасютикълс България ЕООД, България Teva Pharmaceutical Industries Limited, Israel Teva Pharma BV, The Netherlands Pharmachemie B.V., The Netherlands 13.85 2.77 16.62 6% 0.83 14.68 2.94 17.62 18% 2.49 17.17 3.43 20.6 Цената се заличава с решение НСР-2951/07.03.2014 КЦ-700/09.03.2009 24.03.2009 24.03.2009 Заличен 659
Alfacalcidol II - 15922/29.12.2006 Alpha D3, Capsule, soft, 0.5, mcg, Pack: 30 Тева Фармасютикълс България ЕООД, България Teva Pharmaceutical Industries Limited, Israel Teva Pharma BV, The Netherlands Pharmachemie B.V., The Netherlands 9.06 1.81 10.87 7% 0.63 9.69 1.94 11.63 20% 1.81 11.5 2.3 13.8 КЦ-700/09.03.2009 24.03.2009 24.03.2009 Неактивен 2306
Alfacalcidol II - 15921/29.12.2006 Alpha D3, Capsule, soft, 0.25, mcg, Pack: 30 Тева Фармасютикълс България ЕООД, България Teva Pharmaceutical Industries Limited, Israel Teva Pharma BV, The Netherlands Pharmachemie B.V., The Netherlands 6.2 1.24 7.44 7% 0.43 6.63 1.33 7.96 20% 1.24 7.87 1.57 9.44 КЦ-700/09.03.2009 24.03.2009 24.03.2009 Неактивен 2305
Coagulation factor IX EU/1/16/1098/005 Alprolix, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция 5486.34 1097.27 6583.61 4% 10 5496.34 1099.27 6595.61 16% 25 5521.34 1104.27 6625.61 НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17528/13.12.2018; НСР-20369/12.12.2019; НСР-22157/13.08.2020 28.08.2020 02.09.2020 Активен 15908
Coagulation factor IX EU/1/16/1098/005 Alprolix, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция 5617.93 1123.59 6741.52 4% 10 5627.93 1125.59 6753.52 16% 25 5652.93 1130.59 6783.52 НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17528/13.12.2018; НСР-20369/12.12.2019 27.12.2019 02.01.2020 Неактивен 15908
Coagulation factor IX EU/1/16/1098/004 Alprolix, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция 3657.56 731.51 4389.07 4% 10 3667.56 733.51 4401.07 16% 25 3692.56 738.51 4431.07 НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17526/13.12.2018; НСР-20370/12.12.2019; НСР-22158/13.08.2020 28.08.2020 02.09.2020 Активен 15907
Coagulation factor IX EU/1/16/1098/004 Alprolix, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция 3745.28 749.06 4494.34 4% 10 3755.28 751.06 4506.34 16% 25 3780.28 756.06 4536.34 НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17526/13.12.2018; НСР-20370/12.12.2019 27.12.2019 02.01.2020 Неактивен 15907
Coagulation factor IX EU/1/16/1098/003 Alprolix, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция 1828.78 365.76 2194.54 4% 10 1838.78 367.76 2206.54 16% 25 1863.78 372.76 2236.54 НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17525/13.12.2018; НСР-20371/12.12.2019; НСР-22159/13.08.2020 28.08.2020 02.09.2020 Активен 15906
Coagulation factor IX EU/1/16/1098/003 Alprolix, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция 1872.65 374.53 2247.18 4% 10 1882.65 376.53 2259.18 16% 25 1907.65 381.53 2289.18 НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17525/13.12.2018; НСР-20371/12.12.2019 27.12.2019 02.01.2020 Неактивен 15906
Coagulation factor IX EU/1/16/1098/002 Alprolix, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция 914.39 182.88 1097.27 4% 10 924.39 184.88 1109.27 16% 25 949.39 189.88 1139.27 НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17515/13.12.2018; НСР-20372/12.12.2019; НСР-22160/13.08.2020 28.08.2020 02.09.2020 Активен 15905
Coagulation factor IX EU/1/16/1 098/002 Alprolix, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция 936.31 187.26 1123.57 4% 10 946.31 189.26 1135.57 16% 25 971.31 194.26 1165.57 НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17515/13.12.2018; НСР-20372/12.12.2019 27.12.2019 02.01.2020 Неактивен 15905
Coagulation factor IX EU/1/16/1098/001 Alprolix, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция 457.19 91.44 548.63 4% 10 467.19 93.44 560.63 16% 25 492.19 98.44 590.63 НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17527/13.12.2018; НСР-20373/12.12.2019; НСР-22163/13.08.2020 28.08.2020 02.09.2020 Активен 15904
Coagulation factor IX EU/1/16/1098/001 Alprolix, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция 468.17 93.63 561.8 4% 10 478.17 95.63 573.8 16% 25 503.17 100.63 603.8 НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17527/13.12.2018; НСР-20373/12.12.2019 27.12.2019 02.01.2020 Неактивен 15904
Показва 525 до 549 от общо 17974 записа
Линк за сваляне в CSV формат: Копирай
Линк за сваляне в JSON формат: Копирай
Линк за сваляне в XML формат: Копирай
 

Моля изчакайте